Insights provides context and perspective about key pharmacy trends and issues

Pipeline Therapies Could Expand Choices for Conditions with Limited Options | Payor Solutions | CVS Health
Drug Pipeline
Our periodic gene therapy report helps payor better understand the potential for these innovative treatments to transform patient care and outcomes More
Briefing
Treatment Options Expanding for Atopic Dermatitis
Drug Pipeline
A range of new treatment options for AD are expected to come to market in the next couple years. Effective management strategies can help payors manage cost. More
Briefing
Speciality Pharmacy Pipeline Drugs to Watch | Q1 - Q2 2021
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q1 - Q2 2021 More
Specialty Report
Drug Pipeline
Our periodic gene therapy report helps payor better understand the potential for these innovative treatments to transform patient care and outcomes More
Briefing
Speciality Pharmacy Pipeline Drugs to Watch | Q4 2020 - Q1 2021
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q4 2020 - Q1 2021 More
Specialty Report
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q3-Q4 2020 More
Specialty Report
Drug Pipeline
Over the past dozen years, several new treatments have come to market with the first oral preventive expected to be approved in December. Targeted management to help balance access and cost... More
Feature
View article
Drug Pipeline
Updates on the robust gene therapy pipeline from CVS Health pipeline team to help payors stay abreast of this very important emerging category. More
Briefing
Drug Pipeline
After many years of failure, there is hope for potential treatments that could slow disease progression for those with Alzheimer's Disease. If approved, Biogen's aducanumab will... More
Feature
Drug Pipeline
Key drugs to watch for in the specialty pharmacy pipeline Q2-Q3 2020 More
Specialty Report